Improving gold nanorod delivery to the central nervous system by conjugation to the shuttle Angiopep-2

被引:38
作者
Velasco-Aguirre, Carolina [1 ]
Morales-Zavala, Francisco [1 ]
Salas-Huenuleo, Edison [1 ]
Gallardo-Toledo, Eduardo [1 ]
Andonie, Oscar [2 ]
Munoz, Luis [2 ]
Rojas, Ximena [2 ]
Acosta, Gerardo [3 ,4 ]
Sanchez-Navarro, Macarena [5 ]
Giralt, Ernest [3 ]
Araya, Eyleen [6 ]
Albericio, Fernando [3 ,4 ,7 ]
Javier Kogan, Marcelo [1 ]
机构
[1] Univ Chile, Adv Ctr Chron Dis ACCDiS, Fac Ciencias Quim & Farmaceut, Dept Quim Farmacol & Toxicol, Santiago, Chile
[2] CCHEN, Comis Chilena Energia Nucl, Secc Metrol Quim, Nueva Bilbao 12501, Santiago, Chile
[3] Univ Barcelona, Dept Inorgan & Organ Chem, Marti i Franques 1, E-08028 Barcelona, Spain
[4] CIBER BBN, Networking Ctr Bioengn Biomat & Nanomed, Barcelona Sci Pk, Barcelona 08028, Spain
[5] Barcelona Inst Sci & Technol, Inst Res Biomed IRB Barcelona, Baldiri Reixac 10, Barcelona 08028, Spain
[6] Univ Andres Bello, Fac Ciencias Exactas, Dept Ciencias Quim, Republica 275, Santiago 8370146, Chile
[7] Univ KwaZulu Natal, Sch Chem & Phys, ZA-4001 Durban, South Africa
关键词
angiopep-2; blood-brain barrier; drug delivery; gold nanoparticle; gold nanorods; photothermal effect; theranostics; BRAIN DELIVERY; POLY(ETHYLENE GLYCOL); NANOPARTICLES; PEPTIDE; PROTEIN; DRUG; DOXORUBICIN; BIODISTRIBUTION; STABILITY; TRANSPORT;
D O I
10.2217/nnm-2017-0181
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Aim: To improve the in vivo delivery of gold nanorods (GNRs) to the central nervous system of rats, these gold nanoparticles were conjugated to Angiopep-2, a shuttle peptide that can cross the blood-brain barrier. Materials & methods: GNRs were synthesized and modified using polyethylene glycol and Angiopep-2 (GNR-PEG-Angiopep-2). The physicochemical properties, in vitro cytotoxicity and ex vivo biodistribution of the conjugate were examined. Results: GNR-PEG-Angiopep-2 was stable over the following days, and the different concentrations that were tested did not affect the viability of microvascular endothelial cells. The conjugation of Angiopep-2 to GNRs enhanced the endocytosis of these particles (in vitro) and the accumulation in brains (in vivo), when compared with GNRs modified only with PEG. Conclusion: This study provides evidence that Angiopep-2 improves the delivery of GNRs to the brain parenchyma. This property is highly relevant for future applications of GNRs as platforms for photothermal and theranostic purposes.
引用
收藏
页码:2503 / 2517
页数:15
相关论文
共 50 条
  • [21] Glioma cell-targeting doxorubicin delivery and redox-responsive release using angiopep-2 decorated carbonaceous nanodots
    Chen, Jiantao
    Cun, Xingli
    Ruan, Shaobo
    Wang, Yang
    Zhang, Yanling
    He, Qin
    Gao, Huile
    RSC ADVANCES, 2015, 5 (70) : 57045 - 57049
  • [22] Nanomaterials for delivery of nucleic acid to the central nervous system (CNS)
    Wang, Danyang
    Wu, Lin-Ping
    MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS, 2017, 70 : 1039 - 1046
  • [23] Glioma-sensitive delivery of Angiopep-2 conjugated iron gold alloy nanoparticles ensuring simultaneous tumor imaging and hyperthermia mediated cancer theranostics
    Hsu, Sanford P. C.
    Dhawan, Udesh
    Tseng, Yuan-Yun
    Lin, Ching-Po
    Kuo, Ching-Yu
    Wang, Li-Fang
    Chung, Ren-Jei
    APPLIED MATERIALS TODAY, 2020, 18
  • [24] Low-Level Endothelial TRAIL-Receptor Expression Obstructs the CNS-Delivery of Angiopep-2 Functionalised TRAIL-Receptor Agonists for the Treatment of Glioblastoma
    Krishna Moorthy, Nivetha
    Seifert, Oliver
    Eisler, Stephan
    Weirich, Sara
    Kontermann, Roland E.
    Rehm, Markus
    Fullstone, Gavin
    MOLECULES, 2021, 26 (24):
  • [25] Antitumour activity of ANG1005, a conjugate between paclitaxel and the new brain delivery vector Angiopep-2
    Regina, A.
    Demeule, M.
    Che, C.
    Lavallee, I.
    Poirier, J.
    Gabathuler, R.
    Beliveau, R.
    Castaigne, J-P
    BRITISH JOURNAL OF PHARMACOLOGY, 2008, 155 (02) : 185 - 197
  • [26] Intranasal delivery of biologics to the central nervous system
    Lochhead, Jeffrey J.
    Thorne, Robert G.
    ADVANCED DRUG DELIVERY REVIEWS, 2012, 64 (07) : 614 - 628
  • [27] Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector Angiopep-2
    Demeule, Michel
    Currie, Jean-Christophe
    Bertrand, Yanick
    Che, Christian
    Nguyen, Tran
    Regina, Anthony
    Gabathuler, Reinhard
    Castaigne, Jean-Paul
    Beliveau, Richard
    JOURNAL OF NEUROCHEMISTRY, 2008, 106 (04) : 1534 - 1544
  • [28] Delivery of Copper-chelating Trientine (TETA) to the central nervous system by surface modified liposomes
    Tremmel, Robin
    Uhl, Philipp
    Helm, Frieder
    Wupperfeld, Dominik
    Sauter, Max
    Mier, Walter
    Stremmel, Wolfgang
    Hofhaus, Goetz
    Fricker, Gert
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2016, 512 (01) : 87 - 95
  • [29] Nanoparticle delivery for central nervous system diseases and its clinical application
    Tang, Lin
    Zhang, Rui
    Wang, Yusi
    Liu, Mohan
    Hu, Die
    Wang, Yuanda
    Yang, Li
    NANO RESEARCH, 2024, 17 (07) : 6305 - 6322
  • [30] Ionizable nanoemulsions for RNA delivery into the central nervous system - importance of diffusivity
    Borrajo, Mireya L.
    Quijano, Aloia
    Lapuhs, Philipp
    Rodriguez-Perez, Ana I.
    Anthiya, Shubaash
    Labandeira-Garcia, Jose L.
    Valenzuela, Rita
    Alonso, Maria Jose
    JOURNAL OF CONTROLLED RELEASE, 2024, 372 : 295 - 303